Neogenomics Overview
Neogenomics Target Price
Analysts' 12-month price predictions for NEO.
Get informed when a big investor buys or sells
+ FollowShare Price
$11.47
Average Target Price
$19.00
65.6% upside
65.6% upside2 analysts in the last 4 months
High: $25 | Low: $13
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-29 | Leerink Partners | $25 | 118% upside |  |
| 2026-02-24 | Piper Sandler | $13 | 13.3% upside | |
| 2025-10-28 | Leerink Partners | $14 | 22.1% upside | |
| 2025-09-02 | Stephens | $11 |  4.1% downside | |
| 2025-08-04 | Piper Sandler | $11 | 4.1% downside | |
| 2025-07-30 | Morgan Stanley | $8 | 30.3% downside | |
| 2025-07-29 | Needham | $8 | 30.3% downside | |
| 2025-05-06 | Piper SandlerDavid Westenberg | $12 | 4.6% upside | |
| 2025-01-11 | BTIGMark Massaro | $18 | 56.9% upside | |
| 2024-07-30 | NeedhamMike Matson | $19 | 65.6% upside | |
| 2024-05-02 | BTIGMark Massaro | $21 | 83.1% upside | |
| 2023-08-21 | StephensMason Carrico | $18 | 56.9% upside | |
| 2022-08-17 | Piper SandlerDavid Westenberg | $19 | 65.6% upside | |
| 2022-08-10 | Morgan Stanley | $18 | 56.9% upside | |
| 2022-08-10 | Goldman Sachs | $20 | 74.4% upside | |
| 2022-08-10 | Needham | $16 | 39.5% upside | |
| 2022-04-28 | Raymond James | $15 | 30.8% upside | |
| 2021-06-03 | Goldman SachsMatthew Sykes | $55 | 379.5% upside | |
| 2021-05-25 | GuggenheimSandy Draper | $54 | 370.8% upside | |